Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Madhusubramanian Muthukumar, Kamal Desai, Seye Abogunrin, Timothy Harrower, Sylvie Gabriel & Jerome Dinet. (2017) Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom. ClinicoEconomics and Outcomes Research 9, pages 211-229.
Read now
Read now
Articles from other publishers (4)
Justin R. Shinn, Nkechi N. NwabuezePriyesh PatelCathey NortonW. Russell RiesScott J. Stephan. (2018) Contemporary Review and Case Report of Botulinum Resistance in Facial Synkinesis. The Laryngoscope 129:10, pages 2269-2273.
Crossref
Crossref
Jurij R. Bilyk, Michael T. Yen, Elizabeth A. Bradley, Edward J. Wladis & Louise A. Mawn. (2018) Chemodenervation for the Treatment of Facial Dystonia. Ophthalmology 125:9, pages 1459-1467.
Crossref
Crossref
Francesco Scaglione. (2016) Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice. Toxins 8:3, pages 65.
Crossref
Crossref
. (2015) AbobotulinumtoxinA cost-saving option for cervical dystonia. PharmacoEconomics & Outcomes News 737:1, pages 7-7.
Crossref
Crossref